1. Home
  2. IOVA vs MTA Comparison

IOVA vs MTA Comparison

Compare IOVA & MTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.60

Market Cap

881.3M

Sector

Health Care

ML Signal

HOLD

Logo Metalla Royalty & Streaming Ltd.

MTA

Metalla Royalty & Streaming Ltd.

HOLD

Current Price

$7.62

Market Cap

766.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
MTA
Founded
2007
1983
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
881.3M
766.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IOVA
MTA
Price
$2.60
$7.62
Analyst Decision
Buy
Hold
Analyst Count
12
1
Target Price
$10.45
$9.00
AVG Volume (30 Days)
12.8M
648.0K
Earning Date
02-26-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$250,425,000.00
$10,546,000.00
Revenue This Year
$60.71
$127.20
Revenue Next Year
$59.52
$75.15
P/E Ratio
N/A
N/A
Revenue Growth
175.62
108.91
52 Week Low
$1.64
$2.53
52 Week High
$6.36
$8.96

Technical Indicators

Market Signals
Indicator
IOVA
MTA
Relative Strength Index (RSI) 51.15 40.22
Support Level $2.21 $8.05
Resistance Level $3.03 $8.91
Average True Range (ATR) 0.20 0.47
MACD 0.00 -0.10
Stochastic Oscillator 48.78 17.58

Price Performance

Historical Comparison
IOVA
MTA

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About MTA Metalla Royalty & Streaming Ltd.

Metalla Royalty & Streaming Ltd is a precious metals royalty and streaming company, which engages in the acquisition and management of precious metal royalties, streams, and similar production-based interests. It's a pure-play gold and silver streaming and royalty company. It generates revenue from royalties, streams, and other interests.

Share on Social Networks: